first
outbreak
sever
acut
respiratori
syndrom
sar
limit
number
coronavirus
known
circul
human
caus
mild
ill
common
cold
follow
sar
pandem
becam
appar
coronavirus
could
cross
speci
barrier
caus
lifethreaten
infect
human
therefor
attent
need
paid
new
coronavirus
centuri
seen
worldwid
spread
two
previous
unrecogn
coronavirus
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
highli
pathogen
start
novemb
china
unpreced
nosocomi
transmiss
person
person
sarscov
accompani
high
fatal
rate
unit
global
effort
led
rapid
identif
sar
coronaviru
remark
scientif
advanc
epidem
prevent
addit
zoonot
transmiss
sar
decemb
januari
provid
insight
research
origin
novel
coronaviru
notabl
sar
pandem
declar
infect
patient
detect
subsequ
certain
sarscovlik
virus
found
bat
demonstr
abil
infect
human
cell
without
prior
adapt
indic
possibl
reemerg
sarscov
sarscovlik
virus
decad
later
june
anoth
highli
pathogen
novel
coronaviru
merscov
isol
sputum
male
patient
die
acut
pneumonia
renal
failur
saudi
arabia
nosocomi
infect
report
intern
travel
led
transmiss
merscov
countri
outsid
arabian
peninsula
caus
becom
global
pathophoresi
may
outbreak
mer
occur
south
korea
due
individu
return
middl
east
base
lesson
learn
manag
sarscov
preval
last
decad
tremend
progress
toward
unravel
biolog
characterist
merscov
achiev
unpreced
speed
scientif
advanc
allow
rapid
system
progress
understand
epidemiolog
pathogenesi
merscov
sarscov
merscov
share
sever
import
common
featur
contribut
nosocomi
transmiss
preferenti
viral
replic
lower
respiratori
tract
viral
immunopatholog
review
highlight
epidemiolog
pathogenesi
virus
includ
current
understand
biolog
characterist
transmiss
replic
host
spike
protein
protein
cov
play
pivot
role
viral
infect
pathogenesi
critic
surfaceloc
trimer
glycoprotein
cov
guid
entri
host
cell
review
summar
structur
function
protein
therapeut
design
target
moreov
explor
interact
caus
pathogen
outcom
discuss
potenti
treatment
option
well
describ
recent
mammalian
model
close
recapitul
pathogen
process
contribut
develop
prevent
treatment
strategi
sarscov
merscov
although
sever
potenti
therapi
identifi
sar
mer
anim
vitro
model
human
clinic
trial
remain
lack
hinder
advanc
potenti
countermeasur
prior
outbreak
sar
mer
clinic
import
epidem
possibl
cov
recogn
research
tabl
sar
epidem
origin
guangdong
provinc
china
result
death
among
patient
countri
identifi
sar
first
new
infecti
diseas
centuri
ten
year
later
world
health
organ
publish
laboratoryconfirm
case
merscov
occur
septemb
least
death
countri
remark
recent
research
virolog
genet
infect
indic
bat
could
possibl
natur
reservoir
sar
merscov
palm
civet
dromedari
camel
also
possibl
intermediari
host
sar
mer
respect
dissemin
human
transmiss
mechan
sarscov
merscov
yet
fulli
understood
transmiss
anim
human
direct
contact
intermediari
host
might
one
rout
recent
report
demonstr
camel
worker
saudi
arabia
high
preval
merscov
infect
may
contribut
transmiss
mer
custom
habit
may
also
conduc
transmiss
consumpt
milk
urin
uncook
meat
way
merscov
transmit
dromedari
camel
directli
human
princip
arabian
peninsula
consid
main
rout
transmiss
anim
human
caus
signific
morbid
mortal
humantohuman
spread
also
detect
especi
nosocomi
transmiss
delay
diagnosi
hospit
might
lead
secondari
case
among
healthcar
worker
famili
member
patient
share
room
among
report
case
sar
healthcar
worker
china
healthcar
worker
canada
nosocomi
transmiss
mer
similarli
seen
middl
east
republ
korea
outbreak
countri
result
report
case
middl
east
north
africa
transmiss
result
intern
travel
sar
mer
caus
larg
outbreak
signific
public
health
econom
consequ
although
current
understand
pathogenesi
sarscov
merscov
infect
remain
unclear
summar
present
known
tabl
coronavirus
largest
kind
positivestrand
rna
virus
kb
nm
diamet
compris
four
genera
alpha
beta
gamma
deltacoronaviru
current
six
human
cov
hcov
confirm
belong
alphacoronaviru
genu
sarscov
merscov
belong
betacoronaviru
genu
sarscov
merscov
two
major
caus
sever
pneumonia
human
share
common
coronaviru
structur
characterist
similarli
genom
organ
typic
coronavirus
envelop
singl
positivestrand
rna
genom
encod
four
major
viral
structur
protein
name
spike
envelop
e
membran
nucleocapsid
n
protein
follow
characterist
gene
order
rep
gene
spike
envelop
e
membran
nucleocapsid
n
short
untransl
region
termini
figur
viral
membran
contain
e
protein
spike
protein
play
vital
function
role
viral
entri
rep
gene
encod
nonstructur
protein
constitut
approxim
twothird
genom
end
detail
protein
charg
receptorbind
subsequ
viral
entri
host
cell
therefor
major
therapeut
target
e
protein
play
import
role
viral
assembl
n
protein
necessari
rna
synthesi
sarscov
genom
nucleotid
length
includ
open
read
frame
orf
sarscov
rep
gene
contain
twothird
genom
encod
least
two
polyprotein
encod
undergo
process
cotransl
proteolysi
group
group
coronavirus
gene
encod
hemagglutininesteras
detect
sarscov
viru
significantli
differ
previous
report
coronavirus
mani
reason
short
anchor
protein
specif
number
locat
small
orf
presenc
one
copi
plppro
merscov
genom
larger
sarscov
nucleotid
length
compris
termin
cap
structur
along
poli
tail
end
well
rep
gene
contain
nonstructur
protein
end
genom
four
structur
protein
e
n
five
accessori
protein
constitut
kb
end
genom
unlik
betacoronavirus
merscov
genom
encod
hemagglutininesteras
protein
genom
analysi
merscov
impli
potenti
genet
recombin
merscov
outbreak
merscov
sarscov
possess
five
eight
accessori
protein
respect
might
help
viru
evad
immun
system
harm
innat
immun
respons
differ
might
lead
greater
sensit
effect
induct
signal
type
interferon
ifn
merscov
sarscov
sar
mer
caus
sever
pneumonia
result
novel
coronavirus
share
similar
pathogenesi
figur
sar
emerg
infecti
viral
diseas
character
sever
clinic
manifest
lower
respiratori
tract
result
diffus
alveolar
damag
sarscov
spread
respiratori
secret
droplet
via
direct
persontoperson
contact
upon
exposur
host
viru
viru
bind
cell
express
viru
receptor
angiotensinconvert
enzym
one
main
receptor
altern
receptor
much
lower
affin
respiratori
tract
wide
express
epitheli
cell
alveoli
trachea
bronchi
bronchial
serou
gland
alveolar
monocyt
macrophag
viru
enter
replic
target
cell
matur
virion
releas
primari
cell
infect
new
target
cell
furthermor
surfac
molecul
also
diffus
local
endotheli
cell
arteri
vein
mucos
cell
intestin
tubular
epitheli
cell
kidney
epitheli
cell
renal
tubul
cerebr
neuron
immun
cell
provid
varieti
suscept
cell
sarscov
respiratori
secret
urin
stool
sweat
patient
sar
contain
infect
viral
particl
may
excret
contamin
environ
atyp
pneumonia
rapid
respiratori
deterior
failur
induc
sarscov
infect
increas
level
activ
proinflammatori
chemokin
cytokin
merscov
infect
human
primari
receptor
multifunct
cell
surfac
protein
dipeptidyl
peptidas
also
known
wide
express
epitheli
cell
kidney
alveoli
small
intestin
liver
prostat
activ
leukocyt
consist
merscov
infect
sever
human
cell
line
includ
lower
respiratori
kidney
intestin
liver
cell
well
histiocyt
shown
celllin
suscept
studi
indic
rang
merscov
tissu
tropism
vitro
broader
cov
merscov
caus
acut
highli
lethal
pneumonia
renal
dysfunct
variou
clinic
symptom
restrict
cough
sore
throat
myalgia
chest
pain
diarrhea
vomit
abdomin
pain
lung
infect
mer
anim
model
demonstr
infiltr
neutrophil
macrophag
alveolar
edema
entri
receptor
merscov
also
highli
express
kidney
caus
renal
dysfunct
either
hypox
damag
direct
infect
epithelia
remark
unlik
sarscov
merscov
abil
infect
human
dendrit
cell
macrophag
vitro
thu
help
viru
disrupt
immun
system
cell
anoth
target
merscov
high
amount
viru
might
deregul
antivir
tcell
respons
due
stimul
tcell
apoptosi
merscov
might
also
lead
immun
dysregul
stimul
attenu
innat
immun
respons
delay
proinflammatori
cytokin
induct
vitro
vivo
trimer
protein
make
spike
sarscov
provid
format
surfac
glycoprotein
precursor
protein
amino
terminu
situat
outsid
viru
particl
cell
surfac
expect
structur
protein
compris
four
part
signal
peptid
locat
n
terminu
amino
acid
extracellular
domain
amino
acid
transmembran
domain
amino
acid
intracellular
domain
amino
acid
proteas
factor
xa
trypsin
cathepsin
l
cleav
sarscov
protein
two
subunit
subunit
minim
receptorbind
domain
rbd
locat
subunit
amino
acid
combin
host
cell
receptor
rbd
display
concav
surfac
interact
receptor
entir
receptorbind
loop
known
receptorbind
motif
rbm
amino
acid
locat
rbd
respons
complet
contact
importantli
two
residu
rbm
posit
determin
progress
sar
diseas
tropism
sarscov
recent
studi
use
civet
mice
rat
demonstr
chang
two
residu
might
improv
animaltohuman
humantohuman
transmiss
facilit
effici
crossspeci
infect
subunit
mediat
fusion
sarscov
target
cell
includ
heptad
repeat
domain
whose
region
longer
region
similar
sarscov
infect
process
protein
merscov
cleav
receptorbind
subunit
membranefus
subunit
merscov
subunit
also
includ
rbd
mediat
attach
viru
target
cell
unlik
sarscov
merscov
requir
also
known
cellular
receptor
rbd
merscov
sarscov
differ
although
share
high
degre
structur
similar
core
subdomain
explain
differ
critic
receptor
note
core
subdomain
rbd
stabil
three
disulfid
bond
includ
fivestrand
antiparallel
sever
connect
helic
rbm
compris
fourstrand
antiparallel
connect
core
via
loop
two
nlink
glycan
seat
core
rbm
respect
particularli
residu
rbm
take
charg
interact
extracellular
domain
fusion
core
format
merscov
resembl
sarscov
howev
differ
coronavirus
mous
hepat
viru
mhv
sarscov
protein
play
pivot
role
viral
infect
pathogenesi
subunit
recogn
bind
host
receptor
subsequ
conform
chang
subunit
mediat
fusion
viral
envelop
host
cell
membran
rbd
subunit
respons
viru
bind
host
cell
receptor
function
receptor
sarscov
make
contact
amino
acid
rbd
sarscov
among
residu
rbd
subunit
respons
viru
bind
host
cell
receptor
posit
rbd
posit
play
indispens
role
complex
format
furthermor
rbd
protein
pivot
posit
affin
rbd
influenc
antigen
structur
bind
activ
rbd
prefus
structur
postfus
structur
bind
rbd
subunit
receptor
stimul
conform
chang
accordingli
suppos
fusion
peptid
amino
acid
build
target
cell
membran
host
meanwhil
sixhelix
bundl
fusion
core
structur
made
domain
bring
viral
envelop
target
cell
membran
close
proxim
contribut
fusion
resembl
subunit
sarscov
merscov
subunit
charg
membran
fusion
region
play
essenti
complementari
role
furthermor
sarscov
display
altern
method
bind
host
cell
via
potenti
receptor
dendrit
cellspecif
intercellular
adhes
nonintegrin
dcsign
andor
liverlymph
nodesign
lsign
two
exampl
receptor
seven
residu
site
posit
protein
display
asparaginelink
glycosyl
crucial
dcsign
lsignmedi
viru
entri
residu
unlik
domain
function
independ
order
control
outbreak
virus
vaccin
develop
sarscov
merscov
variou
approach
differ
vaccin
develop
advantagesdisadvantag
list
tabl
tabl
includ
updat
sarscov
merscov
sinc
sarscovrel
part
modifi
graham
et
al
natur
review
microbiolog
importantli
among
functionalnonfunct
structur
protein
sarscov
merscov
protein
princip
antigen
compon
induc
antibodi
block
virusbind
stimul
host
immun
respons
fuse
neutral
antibodi
andor
protect
immun
system
viru
infect
therefor
protein
select
signific
target
develop
vaccin
note
antibodi
rais
subunit
amino
acid
amino
acid
neutral
infect
sarscov
strain
vero
cell
research
construct
attenu
parainfluenza
viru
encod
fulllength
protein
sarscov
urbani
strain
vaccin
african
green
monkey
vaccin
could
protect
monkey
subsequ
homolog
sarscov
infect
demonstr
highli
effect
immun
protein
studi
mous
model
structur
dna
vaccin
encod
fulllength
protein
sarscov
urbani
strain
induc
tcell
neutralizingantibodi
respons
also
stimul
protect
immun
furthermor
monkey
mice
vaccin
highli
attenu
modifi
vaccin
viru
ankara
encod
fulllength
protein
sarscov
strain
urbani
howev
fulllength
proteinbas
sar
vaccin
may
induc
harm
immun
respons
caus
liver
damag
vaccin
anim
enhanc
infect
challeng
homolog
sarscov
research
thu
concern
safeti
ultim
protect
efficaci
vaccin
includ
fulllength
sarscov
protein
still
commerci
vaccin
avail
merscov
multipl
vaccin
candid
target
protein
respons
viral
entri
develop
includ
subunit
vaccin
recombin
vector
vaccin
dna
vaccin
importantli
compar
region
protein
rbd
fragment
induc
highesttit
igg
antibodi
mice
modifi
vaccin
includ
recombin
vector
ankara
adenovirus
express
merscov
glycoprotein
show
immunogen
mice
attenu
live
vaccin
also
show
protect
function
concern
regard
degre
attenu
intranas
vaccin
cov
n
protein
airway
memori
cell
gener
mediat
protect
follow
cov
challeng
cell
could
induc
antivir
innat
respons
earli
stage
infect
facilit
tcell
respons
stimul
recombin
dendrit
cell
migrat
tcell
mobil
stimul
airway
memori
cell
regard
essenti
part
hcov
vaccin
strategi
cell
target
conserv
epitop
within
n
protein
crossreact
sever
cov
furthermor
dna
vaccin
express
merscov
gene
produc
antigenspecif
humor
cellular
immun
respons
mice
despit
presenc
extens
research
report
sarscov
merscov
therapi
possibl
establish
whether
treatment
benefit
patient
outbreak
absenc
fundament
clinic
proven
effect
antivir
therapi
sarscov
merscov
patient
mainli
receiv
support
care
supplement
divers
combin
drug
sever
approach
consid
treat
infect
sarscov
merscov
tabl
merscovrel
tabl
previous
review
de
wit
et
al
natur
review
microbiolog
includ
use
antibodi
ifn
inhibitor
viral
host
proteas
vital
role
protein
sarscov
make
protein
import
therapeut
target
numer
studi
explor
potenti
therapeut
firstli
peptid
block
deriv
rbd
could
develop
novel
therapeut
sarscov
infect
secondli
peptid
bind
protein
interfer
cleavag
step
inhibit
product
function
subunit
consequ
fusion
viral
envelop
host
cell
membran
thirdli
antisarscov
peptid
block
interact
form
fusionact
core
viral
fusion
inhibitori
activ
micromolar
level
howev
potenti
select
escap
mutant
alter
host
rang
phenotyp
one
disadvantag
strategi
need
modif
furthermor
mous
monoclon
antibodi
mab
target
assort
fragment
sarscov
protein
effect
inhibit
sarscov
infect
seri
neutral
human
mab
gener
b
cell
patient
infect
sarscov
anoth
strategi
use
human
immunoglobulin
transgen
mice
immun
fulllength
sarscov
protein
bind
receptor
exampl
sspecif
mab
similarli
therapeut
agent
develop
merscov
base
protein
basic
restrain
bind
receptor
fusion
membran
protein
therebi
lead
inhibit
merscov
infect
method
mainli
involv
peptid
fusion
inhibitor
antimerscov
neutral
mab
mab
antagonist
proteas
inhibitor
howev
none
antimerscov
cur
agent
approv
commerci
use
human
mous
speci
use
sarscovinfect
anim
model
includ
balbc
mice
relev
transgen
knockout
line
access
base
suscept
anim
signal
transduc
activ
transcript
knockout
myeloid
differenti
primari
respons
knockout
mice
exampl
mous
model
innat
immun
defici
anim
display
sever
effect
diseas
pneumon
bronchiol
weight
loss
often
die
within
day
infect
notabl
young
mice
requir
mutat
passag
age
mice
produc
sarscov
mouseadapt
strain
sever
patholog
lesion
increas
mortal
observ
oneyearold
anim
along
fewer
mutat
miscellan
locat
throughout
genom
intranas
inocul
four
eightweekold
balbc
mice
sarscov
result
nasal
turbin
upper
respiratori
tract
high
titer
viru
replic
lung
lower
respiratori
tract
model
highli
reproduc
without
sign
morbid
mortal
neutral
antibodi
respons
could
gener
subleth
infect
mice
protect
recipi
subsequ
lethal
challeng
probabl
reflect
situat
infect
human
epidem
howev
day
postinfect
pi
viru
replic
respiratori
tract
peak
accompani
massiv
pulmonari
inflamm
pneumon
day
pi
viru
elimin
lung
obviou
viremia
common
longlast
patient
rare
transient
mous
model
mice
could
therefor
use
stabl
reproduc
anim
model
evalu
vaccin
immuneprophylaxi
antivir
drug
sarscov
golden
syrian
chines
hamster
also
evalu
shown
excel
model
sarscov
infect
owe
high
titer
viru
replic
respiratori
tract
associ
diffus
alveolar
damag
interstiti
pneumon
pulmonari
consolid
day
pi
peak
level
viral
replic
detect
lower
respiratori
tract
viru
clear
without
obviou
clinic
ill
day
infect
similarli
mice
infect
hamster
also
produc
protect
neutralizingantibodi
respons
subsequ
sarscov
challeng
result
extrem
high
titer
reproduc
pulmonari
patholog
lesion
sarscovinfect
hamster
anim
model
ideal
studi
immunoprophylaxi
treatment
sar
howev
still
limit
resourc
term
genet
establish
anim
line
accur
immunolog
cellular
biomark
hamster
model
ferret
found
suscept
sarscov
infect
could
also
transmit
viru
low
level
direct
contact
show
divers
clinic
symptom
differ
studi
importantli
ferret
could
develop
fever
characterist
clinic
symptom
sarscovinfect
patient
similar
rodent
model
infect
ferret
sarscov
result
signific
mortal
howev
still
conflict
report
regard
histopatholog
lesion
sever
clinic
observ
ferret
model
requir
investig
sever
speci
nonhuman
primat
nhp
evalu
anim
model
sar
least
six
nhp
speci
test
includ
three
old
world
monkey
rhesu
macaqu
cynomolgu
macaqu
african
green
monkey
three
new
world
monkey
common
marmoset
squirrel
monkey
mustach
tamarin
except
squirrel
monkey
mustach
tamarin
evalu
nhp
speci
facilit
replic
sarscov
viru
replic
detect
respiratori
tract
rhesu
macaqu
cynomolgu
macaqu
african
green
monkey
pneumon
observ
speci
differ
studi
sarsinfect
common
marmoset
display
fever
wateri
diarrhea
pneumon
hepat
unfortun
research
clinic
sign
diseas
cynomolgu
rhesu
macaqu
gave
conflict
result
therefor
need
investig
main
reason
lack
reproduc
studi
may
limit
sampl
size
despit
fact
wildtyp
rodent
suscept
merscov
infect
research
develop
sever
model
mice
suscept
merscov
infect
first
mous
model
mer
infect
report
involv
transduc
anim
recombin
adenoviru
encod
human
molecul
intranas
result
replic
merscov
lung
mous
model
also
show
clinic
symptom
interstiti
pneumonia
includ
inflammatori
cell
infiltr
thicken
alveolar
mild
edema
howev
certain
limit
model
uncontrol
express
distribut
establish
transgen
mice
report
merscov
could
infect
mous
model
effect
howev
similarli
sarscovinfect
transgen
mice
system
express
led
multipl
organ
lesion
result
death
anim
recent
homolog
gene
use
sever
mer
transgen
mous
model
remark
knockin
ki
mice
mous
gene
fragment
displac
homolog
human
fragment
show
effect
receptor
bind
furthermor
mouseadapt
merscov
strain
mersma
includ
mutat
produc
lung
mice
serial
passag
caus
effect
weight
loss
mortal
mous
model
mous
mersma
strain
provid
better
tool
explor
pathogenesi
mer
potenti
novel
treatment
reservoir
merscov
dromedari
camel
show
mild
upper
respiratori
infect
administr
merscov
oronas
infect
merscov
alpaca
close
rel
within
camelida
famili
result
asymptomat
infect
sign
upper
lower
respiratori
tract
diseas
addit
owe
high
cost
rel
larg
size
anim
model
avail
highthroughput
studi
mer
nhp
rhesu
macaqu
common
marmoset
use
model
studi
pathogenesi
mild
merscov
infect
evalu
novel
therapi
human
although
degre
replic
diseas
sever
vari
merscov
caus
transient
lower
respiratori
tract
infect
rhesu
macaqu
associ
pneumonia
clinic
sign
observ
day
pi
resolv
earli
day
pi
rel
mild
clinic
symptom
observ
earli
infect
without
fatal
indic
rhesu
macaqu
recapitul
sever
infect
observ
human
case
howev
treatment
merscovinfect
rhesu
macaqu
ribavirin
decreas
viru
replic
allevi
host
respons
improv
clinic
outcom
infect
merscov
common
marmoset
demonstr
variou
extent
damag
depend
studi
success
reproduc
sever
featur
merscov
infect
human
importantli
one
studi
indic
infect
becam
progress
sever
pneumonia
group
found
merscovinfect
common
marmoset
develop
mild
moder
nonleth
respiratori
diseas
intratrach
administr
reason
host
restrict
none
limit
clinic
symptom
observ
vari
anim
model
complex
interact
host
receptor
function
protein
sar
mer
respect
play
import
predomin
role
context
anim
model
sarscov
infect
research
compar
amino
acid
interact
protein
rbd
sever
speci
agreement
permiss
natur
speci
residu
marmoset
hamster
similar
comparison
mani
residu
mous
differ
meet
decreas
replic
sarscov
mous
cell
lung
young
mice
chang
posit
histidin
asparagin
rat
rel
partial
disrupt
interact
contribut
abrog
bind
interestingli
ferret
permiss
sarscov
infect
interact
residu
differ
mani
residu
civet
ferret
may
result
similar
affin
merscov
residu
protein
rbd
direct
contact
residu
comparison
human
bind
affin
speci
indic
human
highest
affin
protein
merscov
decreas
order
affin
follow
human
hors
camel
goat
bat
evid
demonstr
host
restrict
merscov
remark
depend
sequenc
character
amino
acid
residu
connector
rbd
protein
mice
hamster
cotton
rat
howev
multipl
sever
diseas
rhesu
macaqu
common
marmoset
indic
host
factor
perhap
affect
infect
replic
viru
presenc
scleav
proteas
gener
although
structur
analysi
receptorss
protein
interact
fulli
explain
observ
host
restrict
agre
improv
replic
sever
anim
model
premier
remark
focu
smallanim
model
develop
special
residu
host
affin
import
build
transgen
anim
model
enhanc
permiss
infect
sar
mer
unlik
sarscov
resolv
without
report
case
continu
outbreak
merscov
present
ongo
threat
public
health
note
specif
treatment
current
avail
hcov
research
pathogenesi
hcov
infect
therefor
imper
identifi
appropri
therapeut
target
accordingli
present
prevent
viral
transmiss
utmost
import
limit
spread
mer
enorm
ratio
nosocomi
infect
indic
prevent
measur
hospit
suffici
implement
addit
emerg
zoonot
viru
prevent
transmiss
dromedari
camel
anoth
possibl
reduc
quantiti
mer
case
regard
clinic
therapi
combin
treatment
administ
earli
possibl
aim
synchron
disrupt
viral
replic
inhibit
viral
dissemin
restrain
host
respons
like
suitabl
due
acut
clinic
featur
mer
diffus
lung
damag
import
role
immunopatholog
potenti
treatment
must
undergo
vitro
vivo
studi
select
promis
option
develop
stabl
reproduc
anim
model
mer
especi
nhp
therefor
decis
step
forward
next
step
develop
standard
control
therapi
sar
mer
clinic
trial
human
valid
standard
protocol
dosag
time
accru
data
real
time
futur
outbreak
monitor
specif
advers
effect
help
inform
treatment
comprehens
lesson
experi
result
outbreak
sar
mer
provid
valuabl
insight
advanc
react
futur
emerg
reemerg
infecti
agent
rapid
identif
pathogen
via
effect
diagnost
assay
first
step
follow
implement
prevent
measur
includ
rais
awar
new
agent
report
record
suspect
case
infect
control
manag
medic
facil
studi
current
need
focu
epidemiolog
organ
especi
term
pathogen
transmiss
potenti
reservoir
andor
intermedi
host
anim
model
prophylact
therapeut
approach
promot
follow
fasttrack
clinic
trial
increas
understand
novel
emerg
coronavirus
accompani
increas
opportun
reason
design
therapeut
importantli
understand
basic
inform
aid
public
health
prepared
sarscov
merscov
also
help
prepar
novel
coronavirus
may
emerg
